《生物多样性公约》对中医药保护作用之考量
|
摘要
在国际上,把知识产权与生物多样性保护融合在一起的最为综合化的管制性努力体现在《生物多样性公约》中。其所确立的以惠益分享为主要内容的三原则,为中医药资源获取国际保护提供了纲领性的框架。然而由于各国有关遗传资源保护的正当性至今无法形成一致,统一而有效的国际保护机制的建立仍然不能预期,加之无论在客体的界定、保护的模式抑或实现的途径上,中医药的价值期许与公约都无法完全对接,因此寄希望于中医药国际性保护规则的率先确立是不现实的,尝试从国内法层面寻求制度设计对于保护措施的落实则更具现实性,这也为该问题的研究确立了方向。
The Convention on Biological Diversity is the international convergence of the protection to biological diversity in intellectual property system. As to the traditional Chinese medicine(TCM),it can find its basic protecting framework in the three principles of CBD. However,due to the conflict views in this area,the establishment of a international protection mechanism is still unexpected. And the demand of protecting TCM can not be fully satisfied on the protection objects,protection mode and protecting ways. So it is more realistic that we should research and design the protecting system in domestic law as the first step,not the international law instead.
The Convention on Biological Diversity is the international convergence of the protection to biological diversity in intellectual property system. As to the traditional Chinese medicine(TCM),it can find its basic protecting framework in the three principles of CBD. However,due to the conflict views in this area,the establishment of a international protection mechanism is still unexpected. And the demand of protecting TCM can not be fully satisfied on the protection objects,protection mode and protecting ways. So it is more realistic that we should research and design the protecting system in domestic law as the first step,not the international law instead.
引文
[1]Bryan Bachner(美).张美成译.知识产权与中医药[M].北京:法律出版社,2009:14.
[2]吴汉东.知识产权国际保护制度的变革与发展[J].法学研究,2005,(3):137.
[3]崔国斌.传统知识保护的困境[A].郑成思.专利法研究[C],北京:知识产权出版社,2002.
[4]田文英,潘峰.知识产权框架下基因资源利益分享法律制度构建[J].中国科技论坛,2006,(1):98.
[5]Kimberly-Clark Corp.v.The Procter&Gamble Distributing Co.United States Court Of Appeal For The Federal Circuit,973 F.2d 911;23 U.S.P.Q.2D(BNA)1921(1992).
[6]Idacon Inc.and David B.Hatcher v.Central Forest Inc.United States District Court For The Eastern District Of Oklahoma,3U.S.P.Q.2D(BNA)1079(1986).
[7]Charles R.Mc Manis,The Interface between International Intellectual Property and Environmental Protection:Biodiversity and Biotechnology,Washington University Law Quarterly(1998),p.4.
[8]倪贵荣.《生物多样性公约》的回顾与前瞻[J].上海大学学报,2012(6):12.
[9]崔国斌.知情同意原则的专利法回应[J].环球法律评论,2005,(5):573.
[10]王艳翚,宋晓亭.中医药传统知识利益分享思路建构[J].河北法学,2013,(9):123.
[2]吴汉东.知识产权国际保护制度的变革与发展[J].法学研究,2005,(3):137.
[3]崔国斌.传统知识保护的困境[A].郑成思.专利法研究[C],北京:知识产权出版社,2002.
[4]田文英,潘峰.知识产权框架下基因资源利益分享法律制度构建[J].中国科技论坛,2006,(1):98.
[5]Kimberly-Clark Corp.v.The Procter&Gamble Distributing Co.United States Court Of Appeal For The Federal Circuit,973 F.2d 911;23 U.S.P.Q.2D(BNA)1921(1992).
[6]Idacon Inc.and David B.Hatcher v.Central Forest Inc.United States District Court For The Eastern District Of Oklahoma,3U.S.P.Q.2D(BNA)1079(1986).
[7]Charles R.Mc Manis,The Interface between International Intellectual Property and Environmental Protection:Biodiversity and Biotechnology,Washington University Law Quarterly(1998),p.4.
[8]倪贵荣.《生物多样性公约》的回顾与前瞻[J].上海大学学报,2012(6):12.
[9]崔国斌.知情同意原则的专利法回应[J].环球法律评论,2005,(5):573.
[10]王艳翚,宋晓亭.中医药传统知识利益分享思路建构[J].河北法学,2013,(9):123.